Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Orbimed Advisors Llc
Form 13F · Q2 2026

Orbimed Advisors Llc

CIK 1055951申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$54.0亿
申报组合市值
129
持仓数量
12
Quarters on record
Top 50
持仓数量

Orbimed Advisors Llc——持仓

共 129 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1EWTX Edgewise Therapeutics Inc15.5M+0.0%$6.3亿11.7%
2ELVN Enliven Therapeutics Inc6.8M−14.9%$3.4亿6.4%
3LLY Eli Lilly & Co257,900+8.9%$3.1亿5.7%
4MBX Mbx Biosciences Inc3.4M−5.7%$1.9亿3.5%
5SVA Sinovac Biotech Ltd2.7M+0.0%$1.8亿3.4%
6AZN Astrazeneca Plc915,700+36.6%$1.7亿3.2%
7GPCR Structure Therapeutics Inc2.2M+49.7%$1.2亿2.2%
8SION Sionna Therapeutics Inc2.6M−27.6%$1.1亿2.1%
9CRVS Corvus Pharmaceuticals Inc7.2M+0.0%$1.1亿2.0%
10AVBP Arrivent Biopharma Inc3.0M+0.0%$1.1亿1.9%
11GH Guardant Health Inc583,700+34.1%$8757万1.6%
12ARGX Argenx Se92,880−32.2%$8617万1.6%
13MRK Merck & Co Inc663,400+0.0%$8525万1.6%
14QURE Uniqure Nv1.8M−15.4%$8325万1.5%
15PRAX Praxis Precision Medicines I230,100+33.4%$7704万1.4%
16EW Edwards Lifesciences Corp834,900−32.2%$7553万1.4%
17PRLD Prelude Therapeutics Inc13.7M+25.8%$7315万1.4%
18ABVX Abivax Sa546,522+17.4%$7283万1.3%
19DYN Dyne Therapeutics Inc3.2M+10.9%$7186万1.3%
20NTRA Natera Inc262,000+0.0%$7112万1.3%
21CGON Cg Oncology Inc972,800+2.6%$6912万1.3%
22UNH Unitedhealth Group Inc161,100—$6696万1.2%
23SPRY Ars Pharmaceuticals Inc8.3M+0.0%$6639万1.2%
24ASND Ascendis Pharma A/S244,456—$6520万1.2%
25HUM Humana Inc164,100—$6518万1.2%
26COGT Cogent Biosciences Inc1.7M+422.0%$6507万1.2%
27BSX Boston Scientific Corp1.5M−37.7%$6330万1.2%
28ISRG Intuitive Surgical Inc157,900−24.3%$6279万1.2%
29MLYS Mineralys Therapeutics Inc2.1M+2.8%$5694万1.1%
30ODTX Odyssey Therapeutics Inc3.0M—$5615万1.0%
31XENE Xenon Pharmaceuticals Inc892,471−15.8%$5387万1.0%
32ARQT Arcutis Biotherapeutics Inc2.0M—$5354万1.0%
33BMY Bristol-Myers Squibb Co925,000+0.0%$5330万1.0%
34QTTB Q32 Bio Inc4.1M+83.2%$5259万1.0%
35SYK Stryker Corporation159,100−12.8%$5009万0.9%
36CAI Caris Life Sciences Inc2.8M+0.0%$5002万0.9%
37TMO Thermo Fisher Scientific Inc90,700+95.1%$4547万0.8%
38PVLA Palvella Therapeutics Inc Ne292,360+117.2%$4468万0.8%
39ELV Elevance Health Inc Formerly114,700+0.0%$4436万0.8%
40STTK Shattuck Labs Inc6.3M+0.0%$4376万0.8%
41UPB Upstream Bio Inc5.7M+0.0%$3940万0.7%
42CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In999,000+0.0%$3738万0.7%
43RYTM Rhythm Pharmaceuticals Inc322,900+2.8%$3585万0.7%
44SNDX Syndax Pharmaceuticals Inc1.5M+60.2%$3371万0.6%
45FORTE BIOSCIENCES INC Forte Biosciences Inc1.6M+31.8%$3353万0.6%
46CMPX Compass Therapeutics Inc15.2M+0.0%$3333万0.6%
47NKTR Nektar Therapeutics465,346+69.2%$3249万0.6%
48KRYS Krystal Biotech Inc83,200+20.4%$3092万0.6%
49PHG Koninklijke Philips N V5.7M−8.5%$3028万0.6%
50AXSM Axsome Therapeutics Inc.117,578−45.0%$2878万0.5%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。